Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Queensland Health
Federal Trade Commission
Fish and Richardson
Colorcon
AstraZeneca
Deloitte
Argus Health
Dow

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019009

« Back to Dashboard

NDA 019009 describes MAXAIR, which is a drug marketed by Medicis and Valeant Pharms and is included in two NDAs. Additional details are available on the MAXAIR profile page.

The generic ingredient in MAXAIR is pirbuterol acetate. There are three drug master file entries for this compound. Additional details are available on the pirbuterol acetate profile page.
Summary for 019009
Tradename:MAXAIR
Applicant:Valeant Pharms
Ingredient:pirbuterol acetate
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:AEROSOL, METERED;INHALATIONStrengthEQ 0.2MG BASE/INH
Approval Date:Dec 30, 1986TE:RLD:No

Expired US Patents for NDA 019009

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms MAXAIR pirbuterol acetate AEROSOL, METERED;INHALATION 019009-001 Dec 30, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms MAXAIR pirbuterol acetate AEROSOL, METERED;INHALATION 019009-001 Dec 30, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms MAXAIR pirbuterol acetate AEROSOL, METERED;INHALATION 019009-001 Dec 30, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Fish and Richardson
Chubb
Johnson and Johnson
Dow
UBS
US Army
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.